ngsbra | 1012
BRCA1 and BRCA2 (tissue)
Keywords:
BRCA1
BRCA2
Next Generation Sequencing
Next Generation Sequencing
Status
| Hint |
Whole sequencing: BRCA1, BRCA2 from tissue If negative, we also recommend carrying out an HRD assay to decide on treatment for ovarian cancer (e.g. MyChoice® CDx). To order this analysis, please contact us via contact@viollier.ch or 0848 121 121. This analysis may result in excess information. This will be communicated, unless it is noted otherwise when placing the order. As there may also be indications of hereditary changes, the GUMG shall ensure the patient is informed accordingly (see www.viollier.ch/en/SGMG_consent). tarification: according to Tarmed.
|
|---|---|
| Duration | 5 days |
| Frequency | 2 x per week |
| Method | Next Generation Sequencing |
Price/Rate
| Price |
Price
CHF 0.00
|
|---|---|
| Rate |
Rate
0.00 TP
|
